24 May 2013 - Valeant Pharmaceuticals International, a pharmaceutical company with activities spanning the drug discovery pipeline from target identification through clinical trials and commercialisation, has launched its international headquarters in Laval, Canada, it was reported yesterday.

The company expects the new headquarters to provide tangible benefits for Quebec and its economy.

Valeant chairman and CEO, Michael Pearson, said, 'Our vision is no less than to become the world leader in the dermatology sector and our commitment is to achieve this here from our base in Quebec, one of our centres for dermatology development.'